Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Jefferies Upgrades Aveanna Healthcare Hldgs to Buy, Lowers Price Target to $6

Author: Benzinga Newsdesk | July 21, 2025 07:15am
Jefferies analyst Brian Tanquilut upgrades Aveanna Healthcare Hldgs (NASDAQ:AVAH) from Hold to Buy and lowers the price target from $6.25 to $6.

Posted In: AVAH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist